A large proportion (∼5 percent) of lung adenocarcinoma patients as well as breast and colorectal tumors are found in pathological fusion sections of this gene with portions of ALK gene that produces the EML4-ALK transcript [35, 36]. Here, ALK is linked to colorectal neoplasm.